Erika Hamilton, MD
@ErikaHamilton9
Director of Breast Cancer Research Program at Sarah Cannon Research Institute | Wife | Mom to 2 Girls | Tweets are My Own #Oncology #BCSM, #Cancer, COI at link.
Theresa & the other #clinicaltrial patient volunteers are the heroes of #oncology, these brave 👨👩👧👦 make every drug advance possible. I'm lucky to be Theresa's doctor and I LOVE celebrating these milestones in @SarahCannonDocs clinic, just motivates us to go further faster!
100 cycles on a phase I clinical trial for metastatic disease - THIS is why we do clinical trials - @ErikaHamilton9 @BurrisSkip @VivekSubbiah @SarahCannonDocs\ oncodaily.com/41233.html #AOCNP #BreastCancer #ClinicalTrial #FNPBC #MSN #OncoDaily #Oncology #PrecisionOncology
Picked both girls up from sleep away camp 🏕️ today. One trunk was ungodly heavy. 3 loads of laundry 🧺 by mom later, I discover a massive hand painted boulder in bottom of 8 year olds trunk. SMH. Currently relocated to front yard.

Proud to share my interview in @AMJ_Oncology reflecting on #ASCO25, the future of ADCs, and how we’re turning knowledge into action for patients. emjreviews.com/en-us/amj/onco… Thanks to @SarahCannonDocs @SCRIOncology for the support and collaboration. #BreastCancer #ClinicalTrials
Volunteering with @ASCO has been one of the most rewarding experiences of my career—united by a common mission, inspired by global impact, and enriched by working along side incredible colleagues. Grateful to now be recognized as FASCO after 100+ hours of service. 💙🌍 #FASCO
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiVu
Was very grateful to @chadinabhan for sharing his platform with me I’m a patient-physician but always live on the front part of that hyphenate and can’t avoid seeing new oncology data through the lens of embodied experience #asco25 cc: @ErikaHamilton9 @ASCO @ConquerCancerFd
THE @marklewismd spent 11 quick minutes on #HUExpress #HealthcareUnfiltered Express sharing the patient/doctor perspective on this past @ASCO #ASCO25 meeting. How can we assure patients' engagement and how to make the data interpretable & digestible. Join the conversation.
These are some amazing members of "Team Hamilton enrollment" celebrating with dinner. From NPs to research nurses to our PhD in personalized medicine, #Clinicaltrials take a village. Appreciate their hard work for our pts immensely! @SCRIOncology @SarahCannonDocs

Fantastic view and such a great model for everyone that looks up to him. You can be passionate about your career, set high goals, etc. without it being your entire life. Remember to have perspective on what truly makes your ❤️ happy and your life fulfilled.
Scottie Scheffler just gave one of the best (and deepest) press conference answers ever heard.
⏳Last chance to join us at The Country Music Hall of Fame for the Women’s Health #OncLiveSOSS. Hear directly from @ErikaHamilton9 & @DrKatyMoore on the latest in treatment strategies. 🔗 Secure your spot before it’s gone: hubs.li/Q03r4Myj0 @SarahCannonDocs
#HongKong Amazing time with the chair, Dr. Rina Hui, at Hong Kong International Oncology Forum 2025. Great meeting, fantastic hospitality! Btw...@PTarantinoMD self game on #internationalselfieday is strong 💪🏼




🔥📣The 2025 #ASCOEdBook collection from @ASCO #ASCO25 is now complete & fully available (for free). ✅It’s a great resource with very EDUCATIONAL peer-reviewed articles by great experts. Outstanding job by editors & authors.👏 Link to full edition👇🏻 bit.ly/44bvEkk
Small glimpse of *part* of my tribe- a couple of the @SarahCannonDocs crew that so amazingly supports us in every way. My EA Lisa, our #bcsm program manager Mythili, our President and my mentor @BurrisSkip, and of course our CEO @Dee_Anna_Smith (and soon to be @SPremji7866).




Maybe I'm delirious at this point Mon pm at #ASCO25. But I just made myself LOL at McCormick Uber pick up thinking about the study reporting whether the attendants yelling & blowing whistles to "keep moving" does anything to make the cars move faster. Hall B1, predict HR 1.0
Completely agree. Many women make the choice to receive chemo for a benefit less than this. It's HUGE! Ovarian suppression and AI is a powerful tool to decrease recurrences.
Ok the update to the SOFT and TEXT trial is critically important for the general onc community. Please do not put young women on tamoxifen alone as a default. Ovarian suppression and aromatase inhibitor (not tam) is lifesaving. It’s more important than chemo for many #ASCO25
#SOFT and #TEXT looking at AI vs. tam and OFS vs. not, 15 yr f/u 📌Adding OFS gives you 3.7% ⬆️ DFS 📌OFS + AI gets you 6.5% ⬆️ DFS 📍OFS + AI improves gives you ⬆️ 4.3% OS 🌟 Ultra young <35, it's even more important #ASCO25 #bcsm




Not suprising, this is as we thought, but amazing that it was formally tested and done. Sorry..scalp cooling does not work for T-DXd and I would extrapolate to other #ADCs with long half lives. #hairloss #bcsm #ASCO25 #scalpcooling
Does scalp cooling work to prevent alopecia with T-DXd? Check out poster 74, with the FIRST ever PROSPECTIVE clinical trial that looked at this question. And first trial led by a @DFCI_BreastOnc nurse practitioner! Superstar Elahe Salehi #bcsm #ASCO25
Multiple studies looking at neoadjuvant regimens for HER2+ early BC. Looks like THP would suffice for most stage 1 and 2, and Cb not needed. Interesting question as to whether 6 cycles / 18 weeks is > than 4 cycles / 12 weeks. @ASCO #ASCO25 @OncoAlert
Very exciting!!! We need new drugs especially in mTNBC and especially post topo-1 ADCs as they move further up in our treatment paradigm
Particularly excited about the activity in #TNBC post topo-1 ADCs. 86% had seen savituzumab govitecan, 1/3 had seen T-DXd, 1/4 had seen both! #ASCO25 #ADC #NewTargetNewPayload
NeoCARHP: de-escalated HER-2 neoadj thpy for #bcsm 🤩THP non inferior to TCHP in pCR, both HR+ and HR- HER-2+ disease 😅 phew, I'd already been doing this for some older pts 🩸 G3/4 neutropenia ⬇️ by 10% w/ THP Interestingly, neuropathy not different #ASCO25



